Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reirradiation and Erbitux in the HNSCC

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2014 by Groupe Oncologie Radiotherapie Tete et Cou.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Groupe Oncologie Radiotherapie Tete et Cou
ClinicalTrials.gov Identifier:
NCT01237483
First received: November 8, 2010
Last updated: August 12, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)